Clinical management of chronic kidney disease-associated pruritus: current treatment options and future approaches
Author Department
Nephrology; Medicine
Document Type
Article, Peer-reviewed
Publication Date
10-2021
Abstract
Chronic kidney disease (CKD)-associated pruritus (CKD-aP) is an underdiagnosed yet severely distressing condition that impacts 60% of patients on dialysis and many nondialysis patients with Stages 3-5 CKD. However, despite its high prevalence, there are currently limited treatment options available for these patients and a lack of treatment guidelines for clinicians. In this manuscript, we reviewed the available literature in order to evaluate the current management and treatment options for CKD-aP, including dialysis management, topical treatments, gabapentinoids, opioids and alternative medicine. We also review the available data on CKD-aP treatments in development and propose new guidelines for managing patients with CKD-aP.
Keywords: CKD; CKD-aP; ESRD; itch; pruritus; uremic pruritus.
Recommended Citation
Lipman ZM, Paramasivam V, Yosipovitch G, Germain MJ. Clinical management of chronic kidney disease-associated pruritus: current treatment options and future approaches. Clin Kidney J. 2021 Oct 14;14(Suppl 3):i16-i22. doi: 10.1093/ckj/sfab167.
PMID
34987779